(Q36796801)

16 August 2017

Ferumoxytol for treating iron deficiency anemia in CKD (English)

1 reference

16 August 2017

1 reference

iron deficiency anemia

1 reference

Bruce S Spinowitz

1

1 reference

16 August 2017

Annamaria T Kausz

2

1 reference

16 August 2017

Jovanna Baptista

3

1 reference

16 August 2017

Sylvia D Noble

4

1 reference

16 August 2017

Renuka Sothinathan

5

1 reference

16 August 2017

Marializa V Bernardo

6

1 reference

16 August 2017

Louis Brenner

7

1 reference

16 August 2017

Brian J G Pereira

8

1 reference

16 August 2017

4 June 2008

1 reference

Journal of the American Society of Nephrology

16 August 2017

1 reference

16 August 2017

19

1 reference

16 August 2017

8

1 reference

16 August 2017

1599-1605

1 reference

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Safety in iron management

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Intravenous iron sucrose: establishing a safe dose

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Intravenous iron for the treatment of predialysis anemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Strategies for iron supplementation: oral versus intravenous

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Iron management in end-stage renal disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Management of patients with chronic renal insufficiency in the Northeastern United States.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Assessment of iron availability using stable 54Fe

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Clinical practice guidelines for vascular access.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Update on adverse drug events associated with parenteral iron

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Bioavailability of oral iron drugs as judged by a 59Fe-whole-body counting technique in patients with iron deficiency anaemia. Therapeutic efficacy of iron(II)-glycine sulfate

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Hypersensitivity reactions and deaths associated with intravenous iron preparations

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Iron status and hemoglobin level in chronic renal insufficiency

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Anemia: an early complication of chronic renal insufficiency

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Suspected iron dextran-related adverse drug events in hemodialysis patients

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patients.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

The prevalence and significance of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic therapy.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2488268

Correction of anemia with epoetin alfa in chronic kidney disease

5 September 2018

1 reference

12 December 2020

A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD

1 reference

12 December 2020

Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin

1 reference

12 December 2020

Iron and zinc status of patients with chronic renal failure who are not on dialysis

1 reference

12 December 2020

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)

1 reference

12 December 2020

Intravenous Iron Dextran in Clinical Medicine

1 reference

12 December 2020

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

12 December 2020

Cardiac function and hematocrit level

1 reference

12 December 2020

Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era

1 reference

12 December 2020

Randomized cross-over study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patients

1 reference

12 December 2020

Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium

1 reference

12 December 2020

Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis

1 reference

12 December 2020

Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections

1 reference

12 December 2020

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease

1 reference

12 December 2020

II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults

1 reference

12 December 2020

The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2007101156

1 reference

release_vz46leiznraohgqugy4bj4dpci

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vz46leiznraohgqugy4bj4dpci

24 November 2022

mapped directly with Wikidata item

1 reference

16 August 2017

PubMed publication ID

18525001

1 reference